• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.人类有机阳离子转运体hOCT1、hOCT2和hOCT3的表达及药理学特性
Br J Pharmacol. 2002 Jul;136(6):829-36. doi: 10.1038/sj.bjp.0704785.
2
Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.抗抑郁药和抗精神病药与人体有机阳离子转运体 hOCT1、hOCT2 和 hOCT3 的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):1017-23. doi: 10.1007/s00210-012-0781-8. Epub 2012 Jul 18.
3
Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).雷尼替丁和法莫替丁对人有机阳离子转运体1(hOCT1;SLC22A1)、hOCT2(SLC22A2)和hOCT3(SLC22A3)的底物差异及抑制活性
J Pharmacol Exp Ther. 2005 Dec;315(3):1288-97. doi: 10.1124/jpet.105.091223. Epub 2005 Sep 1.
4
Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters.氟哌啶醇的神经毒性吡啶代谢产物是人类有机阳离子转运体的底物。
Drug Metab Dispos. 2006 Jul;34(7):1145-51. doi: 10.1124/dmd.105.009126. Epub 2006 Apr 19.
5
Interaction of six protoberberine alkaloids with human organic cation transporters 1, 2 and 3.六种原小檗碱生物碱与人类有机阳离子转运体1、2和3的相互作用。
Xenobiotica. 2016;46(2):175-83. doi: 10.3109/00498254.2015.1056283. Epub 2015 Jul 2.
6
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).人类有机阳离子转运体(OCT)的药物特异性及肠膜定位
Biochem Pharmacol. 2005 Dec 5;70(12):1851-60. doi: 10.1016/j.bcp.2005.09.011. Epub 2005 Nov 2.
7
Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.二价阳离子药物喷他脒和夫拉米定通过人类有机阳离子转运体的转运
Drug Metab Dispos. 2009 Feb;37(2):424-30. doi: 10.1124/dmd.108.024083. Epub 2008 Oct 29.
8
The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.线粒体荧光染料罗丹明 123 是有机阳离子转运体(OCTs)1 和 2 的高亲和力底物。
Fundam Clin Pharmacol. 2014 Feb;28(1):65-77. doi: 10.1111/j.1472-8206.2012.01071.x. Epub 2012 Aug 23.
9
Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.β-咔啉生物碱对人有机阳离子转运体2(hOCT2)的强效抑制作用。
Xenobiotica. 2017 Dec;47(12):1112-1120. doi: 10.1080/00498254.2016.1271160. Epub 2017 Mar 2.
10
Characterization of -Iodobenzylguanidine (mIBG) Transport by Polyspecific Organic Cation Transporters: Implication for mIBG Therapy.多特异性有机阳离子转运体介导的 -Iodobenzylguanidine(mIBG)转运的特征:对 mIBG 治疗的影响。
Mol Pharmacol. 2020 Aug;98(2):109-119. doi: 10.1124/mol.120.119495. Epub 2020 Jun 2.

引用本文的文献

1
Dopamine internalization via Uptake and stimulation of intracellular D-receptor-dependent calcium mobilization and CDP-diacylglycerol signaling.多巴胺通过摄取内化,并刺激细胞内D受体依赖性钙动员和CDP - 二酰甘油信号传导。
Front Pharmacol. 2024 Oct 25;15:1422998. doi: 10.3389/fphar.2024.1422998. eCollection 2024.
2
Bioisosteric analogs of MDMA: Improving the pharmacological profile?MDMA 的生物等排体:改善药理学特性?
J Neurochem. 2024 Sep;168(9):2022-2042. doi: 10.1111/jnc.16149. Epub 2024 Jun 19.
3
Organic cation transporters in psychiatric and substance use disorders.精神疾病和物质使用障碍中的有机阳离子转运体。
Pharmacol Ther. 2024 Jan;253:108574. doi: 10.1016/j.pharmthera.2023.108574. Epub 2023 Dec 9.
4
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy.溶质载体转运体在高效抗癌药物递送与治疗中的作用
Pharmaceutics. 2023 Jan 21;15(2):364. doi: 10.3390/pharmaceutics15020364.
5
Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in and Organic Cation Transporter OCT2.药物和农药研究揭示 Elacridar 和 Imazalil 对 和 有机阳离子转运蛋白 OCT2 的新型种属和底物依赖性抑制作用。
Int J Mol Sci. 2022 Dec 13;23(24):15795. doi: 10.3390/ijms232415795.
6
Structural basis of organic cation transporter-3 inhibition.有机阳离子转运蛋白 3 抑制的结构基础。
Nat Commun. 2022 Nov 7;13(1):6714. doi: 10.1038/s41467-022-34284-8.
7
High Affinity Decynium-22 Binding to Brain Membrane Homogenates and Reduced Dorsal Camouflaging after Acute Exposure to it in Zebrafish.高亲和力的癸氰碘铵-22与脑匀浆结合以及斑马鱼急性暴露于其之后背侧伪装能力降低
Front Pharmacol. 2022 Jun 9;13:841423. doi: 10.3389/fphar.2022.841423. eCollection 2022.
8
Organic Cation Transporter-Mediated Accumulation of Quinolinium Salts in the LV Myocardium of Rodents.有机阳离子转运体介导的喹啉盐在啮齿动物左心室心肌中的蓄积。
Mol Imaging Biol. 2022 Oct;24(5):1-9. doi: 10.1007/s11307-022-01728-y. Epub 2022 Apr 20.
9
MPP-Induced Changes in Cellular Impedance as a Measure for Organic Cation Transporter (SLC22A1-3) Activity and Inhibition.MPP+ 诱导的细胞阻抗变化作为有机阳离子转运体(SLC22A1-3)活性和抑制的测量指标。
Int J Mol Sci. 2022 Jan 21;23(3):1203. doi: 10.3390/ijms23031203.
10
Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.中枢神经系统活性药物在人有机阳离子转运体 1-3 和人血浆单胺转运体上的相互作用特征。
Int J Mol Sci. 2021 Nov 30;22(23):12995. doi: 10.3390/ijms222312995.

本文引用的文献

1
The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: A novel catechol amine uptake process.大鼠离体心脏在高灌注浓度下对儿茶酚胺的摄取:一种新的儿茶酚胺摄取过程。
Br J Pharmacol Chemother. 1965 Aug;25(1):18-33. doi: 10.1111/j.1476-5381.1965.tb01753.x.
2
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
3
The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines.神经元和神经元外质膜转运体在周围儿茶酚胺失活中的作用。
Pharmacol Ther. 2001 Jul;91(1):35-62. doi: 10.1016/s0163-7258(01)00144-9.
4
Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors.酚苄明结合揭示了肾上腺素能受体第三个跨膜结构域的螺旋取向。
J Biol Chem. 2001 Aug 17;276(33):31279-84. doi: 10.1074/jbc.M104167200. Epub 2001 Jun 6.
5
Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1).人有机阳离子转运体1(hOCT1/SLC22A1)四种可变剪接异构体的分子克隆、功能表征及基因组组织
Ann Hum Genet. 1999 Nov;63(Pt 6):473-82. doi: 10.1017/S0003480099007770.
6
Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters.人肠道Caco-2细胞对有机阳离子的顶端摄取:ASF转运蛋白的可能作用。
Naunyn Schmiedebergs Arch Pharmacol. 2001 Jan;363(1):40-9. doi: 10.1007/s002100000335.
7
Analysis of the gene structure of the human (SLC22A3) and murine (Slc22a3) extraneuronal monoamine transporter.人类(SLC22A3)和小鼠(Slc22a3)细胞外单胺转运体的基因结构分析。
J Neural Transm (Vienna). 2000;107(10):1149-57. doi: 10.1007/s007020070028.
8
Functional expression of a high affinity mammalian hepatic choline/organic cation transporter.一种高亲和力哺乳动物肝脏胆碱/有机阳离子转运体的功能表达。
J Lipid Res. 2000 Nov;41(11):1841-8.
9
Gene structures of the human non-neuronal monoamine transporters EMT and OCT2.人类非神经元单胺转运体EMT和OCT2的基因结构。
Hum Genet. 2000 Jun;106(6):627-35. doi: 10.1007/s004390000309.
10
Structure of renal organic anion and cation transporters.肾有机阴离子和阳离子转运体的结构。
Am J Physiol Renal Physiol. 2000 Jun;278(6):F853-66. doi: 10.1152/ajprenal.2000.278.6.F853.

人类有机阳离子转运体hOCT1、hOCT2和hOCT3的表达及药理学特性

Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.

作者信息

Hayer-Zillgen Martina, Brüss Michael, Bönisch Heinz

机构信息

Institute of Pharmacology and Toxicology, University of Bonn, Reuterstr. 2 b, D-53113 Bonn, Germany.

出版信息

Br J Pharmacol. 2002 Jul;136(6):829-36. doi: 10.1038/sj.bjp.0704785.

DOI:10.1038/sj.bjp.0704785
PMID:12110607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1573414/
Abstract
  1. Organic cation transporters (OCTs) are involved in the elimination of monoamines and cationic xenobiotics. To examine whether some cell lines express several different OCTs, we investigated seven human cell lines for the mRNA expression pattern of the human (h) transporters hOCT1, hOCT2 and hOCT3. hOCT1 mRNA was found in all cell lines, six additionally expressed hOCT3 and only two cell lines contained all three hOCTs. 2. Among the three OCTs only for the OCT3 (also designated as 'uptake(2)' or 'extraneuronal monoamine transporter') 'selective' inhibitors are described in the literature. The affinities of the OCT3 inhibitors for the other two OCTs are largely unknown. Therefore, we compared the potencies of eight compounds as inhibitors of hOCT-mediated uptake of the organic cation [(3)H]-1-methyl-4-phenylpyridinium ([(3)H]-MPP(+)) in human embryonic kidney 293 (HEK293) cells stably expressing hOCT1, hOCT2 or hOCT3. Decynium-22 inhibited hOCT3 with 10 fold higher potency than hOCT1 and hOCT2. Corticosterone was about 100 fold more potent as inhibitor of hOCT3 than of hOCT1 or hOCT2, and O-methylisoprenaline (OMI) inhibited almost exclusively hOCT3. Progesterone and beta-Oestradiol preferentially inhibited hOCT3 and hOCT1, whereas prazosin was a potent inhibitor of hOCT1 and hOCT3. Phenoxybenzamine (PbA) inhibited with about equal apparent potency all three hOCTs, whereas the PbA derivative SKF550 ((9-fluorenyl)-N-methyl-beta-chloroethylamine) preferentially inhibited hOCT3 and hOCT2. 3. PbA reversibly inhibited hOCT1 and irreversibly hOCT2 and hOCT3; SKF550 also irreversibly inhibited hOCT3 but hOCT2 in a reversible manner. 4. These compounds enable a functional discrimination of the three hOCTs: hOCT1 is selectively inhibited by prazosin, reversibly inhibited by PbA and it is not sensitive to inhibition by SKF550 and OMI; hOCT2 is reversibly inhibited by SKF550, irreversibly by PbA and not by prazosin, beta-oestradiol and OMI, whereas hOCT3 is selectively inhibited by corticosterone, OMI and decynium22.
摘要
  1. 有机阳离子转运体(OCTs)参与单胺类物质和阳离子型外源性物质的清除。为了研究某些细胞系是否表达几种不同的OCTs,我们调查了7种人类细胞系中人类(h)转运体hOCT1、hOCT2和hOCT3的mRNA表达模式。在所有细胞系中均发现了hOCT1 mRNA,另外6种细胞系表达hOCT3,只有2种细胞系包含所有3种hOCTs。2. 在这3种OCTs中,文献中仅描述了OCT3(也称为“摄取(2)”或“神经元外单胺转运体”)的“选择性”抑制剂。OCT3抑制剂对其他两种OCTs的亲和力大多未知。因此,我们比较了8种化合物作为hOCT介导的有机阳离子[(3)H]-1-甲基-4-苯基吡啶鎓([(3)H]-MPP(+))摄取抑制剂在稳定表达hOCT1、hOCT2或hOCT3的人胚肾293(HEK293)细胞中的效力。癸氰碘铵抑制hOCT3的效力比hOCT1和hOCT2高10倍。皮质酮作为hOCT3的抑制剂比hOCT1或hOCT2强约100倍,而O-甲基异丙肾上腺素(OMI)几乎只抑制hOCT3。孕酮和β-雌二醇优先抑制hOCT3和hOCT1,而哌唑嗪是hOCT1和hOCT3的有效抑制剂。苯氧苄胺(PbA)以大致相同的表观效力抑制所有3种hOCTs,而PbA衍生物SKF550((9-芴基)-N-甲基-β-氯乙胺)优先抑制hOCT3和hOCT2。3. PbA可逆地抑制hOCT1,不可逆地抑制hOCT2和hOCT3;SKF550也不可逆地抑制hOCT3,但以可逆方式抑制hOCT2。4. 这些化合物能够对3种hOCTs进行功能区分:hOCT1被哌唑嗪选择性抑制,被PbA可逆抑制,对SKF550和OMI的抑制不敏感;hOCT2被SKF550可逆抑制,被PbA不可逆抑制,对哌唑嗪、β-雌二醇和OMI不敏感,而hOCT3被皮质酮、OMI和癸氰碘铵选择性抑制。